BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15273650)

  • 1. The use of pharmacotherapy in the prodrome of schizophrenia.
    Remington G; Shammi C
    CNS Spectr; 2004 Aug; 9(8):579-86. PubMed ID: 15273650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosis treatment prior to psychosis onset: ethical issues.
    McGlashan TH
    Schizophr Res; 2001 Aug; 51(1):47-54. PubMed ID: 11479065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beating psychosis to the punch: the treatment options debate.
    Gorman JM
    CNS Spectr; 2004 Aug; 9(8):572. PubMed ID: 15273647
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of the schizophrenia prodrome: is it presently ethical?
    Cornblatt BA; Lencz T; Kane JM
    Schizophr Res; 2001 Aug; 51(1):31-8. PubMed ID: 11479063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a better identification and treatment of schizophrenia prodrome.
    Bota RG; Sagduyu K; Filin EE; Bota DA; Munro S
    Bull Menninger Clin; 2008; 72(3):210-27. PubMed ID: 18990056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dilemma of early drug intervention in prepsychotic illnesses of adolescence].
    Branik E; Meng H
    Prax Kinderpsychol Kinderpsychiatr; 2003 Dec; 52(10):751-65. PubMed ID: 14699785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis and assessment of individuals prodromal for schizophrenic psychosis.
    Addington J
    CNS Spectr; 2004 Aug; 9(8):588-94. PubMed ID: 15273651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early intervention for schizophrenia: the risk-benefit ratio of antipsychotic treatment in the prodromal phase.
    Weiser M
    Am J Psychiatry; 2011 Aug; 168(8):761-3. PubMed ID: 21813489
    [No Abstract]   [Full Text] [Related]  

  • 9. Prodromal schizophrenia: the dilemma of prediction and early intervention.
    Davidson M; Weiser M
    CNS Spectr; 2004 Aug; 9(8):578. PubMed ID: 15273649
    [No Abstract]   [Full Text] [Related]  

  • 10. First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies.
    Gaebel W; Jänner M; Frommann N; Pietzcker A; Köpcke W; Linden M; Müller P; Müller-Spahn F; Tegeler J
    Schizophr Res; 2002 Jan; 53(1-2):145-59. PubMed ID: 11728846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early intervention in schizophrenia: current and future perspectives.
    Keshavan MS; Amirsadri A
    Curr Psychiatry Rep; 2007 Aug; 9(4):325-8. PubMed ID: 17880865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying vulnerability markers in prodromal patients: a step in the right direction for schizophrenia prevention.
    Knowles L; Sharma T
    CNS Spectr; 2004 Aug; 9(8):595-602. PubMed ID: 15273652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom assessment in schizophrenic prodromal states.
    Miller TJ; McGlashan TH; Woods SW; Stein K; Driesen N; Corcoran CM; Hoffman R; Davidson L
    Psychiatr Q; 1999; 70(4):273-87. PubMed ID: 10587984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
    Crespo-Facorro B; Pelayo-Terán JM; Pérez-Iglesias R; Ramírez-Bonilla M; Martínez-García O; Pardo-García G; Vázquez-Barquero JL
    J Psychiatr Res; 2007 Oct; 41(8):659-66. PubMed ID: 16797591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia.
    Nasrallah HA; Keshavan MS; Benes FM; Braff DL; Green AI; Gur RE; Kane JM; Perkins DO; Weiden PJ; Weinberger DR; Correll CU
    J Clin Psychiatry; 2009; 70 Suppl 1():4-46. PubMed ID: 19292973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical issues in early-intervention clinical trials involving minors at risk for schizophrenia.
    DeGrazia D
    Schizophr Res; 2001 Aug; 51(1):77-86. PubMed ID: 11479069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethics of the early intervention in the treatment of schizophrenia.
    Filaković P; Degmecić D; Koić E; Benić D
    Psychiatr Danub; 2007 Sep; 19(3):209-15. PubMed ID: 17914322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective observations of emerging psychosis.
    Rosen JL; Woods SW; Miller TJ; McGlashan TH
    J Nerv Ment Dis; 2002 Mar; 190(3):133-41. PubMed ID: 11923647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk-benefit ratio of the proposed DSM-5 attenuated psychosis syndrome.
    Woods SW; McGlashan TH
    Am J Psychiatry; 2011 Dec; 168(12):1338; author reply 1338. PubMed ID: 22193675
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary: The schizophrenia prodrome: a high-risk concept.
    Yung AR
    Schizophr Bull; 2003; 29(4):859-65. PubMed ID: 14989420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.